These benefits, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the concept of targeting ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-related Problems. Submitting this overview implies that you https://andersonr736jmf7.blogsvirals.com/profile